128 related articles for article (PubMed ID: 10332687)
1. Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Wägner AM; Pérez A; Calvo F; Bonet R; Castellví A; Ordóñez J
Diabetes Care; 1999 May; 22(5):812-7. PubMed ID: 10332687
[TBL] [Abstract][Full Text] [Related]
2. Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients.
Wägner AM; Pérez A; Zapico E; Ordóñez-Llanos J
Diabetes Care; 2003 Jul; 26(7):2048-51. PubMed ID: 12832311
[TBL] [Abstract][Full Text] [Related]
3. Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients.
Wägner AM; Ordóñez-Llanos J; Hernández M; Sánchez-Quesada JL; Blanco-Vaca F; Rigla M; de Leiva A; Pérez A
Eur J Intern Med; 2001 Dec; 12(6):496-502. PubMed ID: 11711272
[TBL] [Abstract][Full Text] [Related]
4. Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Charlton-Menys V; Betteridge DJ; Colhoun H; Fuller J; France M; Hitman GA; Livingstone SJ; Neil HA; Newman CB; Szarek M; DeMicco DA; Durrington PN
Clin Chem; 2009 Mar; 55(3):473-80. PubMed ID: 19147732
[TBL] [Abstract][Full Text] [Related]
5. [Apolipoprotein B and A-I: cardiovascular risk factor?].
Forti N; Diament J
Rev Assoc Med Bras (1992); 2007; 53(3):276-82. PubMed ID: 17665079
[TBL] [Abstract][Full Text] [Related]
6. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein C subtype distribution in type 2 diabetes mellitus.
Gomez JA; del Pozo C; Sorribas A; Serrat J; Gonzalez-Sastre F; de Leiva A
Diabet Med; 1989 Mar; 6(2):127-30. PubMed ID: 2522853
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study).
Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ
Am J Cardiol; 1995 Jun; 75(17):1189-95. PubMed ID: 7778537
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemic hyperapoB in type 2 diabetes.
Sniderman AD; Lamarche B; Tilley J; Seccombe D; Frohlich J
Diabetes Care; 2002 Mar; 25(3):579-82. PubMed ID: 11874951
[TBL] [Abstract][Full Text] [Related]
10. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
11. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
[TBL] [Abstract][Full Text] [Related]
12. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
13. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
[TBL] [Abstract][Full Text] [Related]
14. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.
Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A
Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496
[TBL] [Abstract][Full Text] [Related]
15. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
Diabetes Atorvastin Lipid Intervention (DALI) Study Group
Diabetes Care; 2001 Aug; 24(8):1335-41. PubMed ID: 11473066
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
[TBL] [Abstract][Full Text] [Related]
19. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Langlois MR; Nordestgaard BG; Langsted A; Chapman MJ; Aakre KM; Baum H; Borén J; Bruckert E; Catapano A; Cobbaert C; Collinson P; Descamps OS; Duff CJ; von Eckardstein A; Hammerer-Lercher A; Kamstrup PR; Kolovou G; Kronenberg F; Mora S; Pulkki K; Remaley AT; Rifai N; Ros E; Stankovic S; Stavljenic-Rukavina A; Sypniewska G; Watts GF; Wiklund O; Laitinen P;
Clin Chem Lab Med; 2020 Mar; 58(4):496-517. PubMed ID: 31855562
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group.
Langlois MR; Descamps OS; van der Laarse A; Weykamp C; Baum H; Pulkki K; von Eckardstein A; De Bacquer D; Borén J; Wiklund O; Laitinen P; Oosterhuis WP; Cobbaert C;
Atherosclerosis; 2014 Mar; 233(1):83-90. PubMed ID: 24529127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
